Advertisement
Ultragenyx Pharmaceutical Inc.

RARE News Today: Stay Updated with the Latest Ultragenyx Pharmaceutical Inc. News in Real Time

Find RARE news now at Meyka AI. Stay informed with the latest Ultragenyx Pharmaceutical Inc. stocks updates, including price news, market analysis, and expert insights.

RARENASDAQ
HealthcareBiotechnology
$22.97
$0.18(0.79%)
U.S. Market opens in 17h 20m
Advertisement
NVIDIA Corp (NVDA -0.22% / -1.78% Pre-Market) Leads AI Chip Stocks Drop as AMD (-3.02%), Intel (-2.13%), and Micron (-1.41%) Decline 
📅 3 hours ago

NVIDIA Corp (NVDA -0.22% / -1.78% Pre-Market) Leads AI Chip Stocks Drop as AMD (-3.02%), Intel (-2.13%), and Micron (-1.41%) Decline 

NVIDIA shares fell 1.78% in pre-market trading on June 10, 2026, leading a broader decline across AI chip stocks. AMD dropped 3.02%, while Intel and Micron also traded lower as investors reacted to renewed concerns over inflation, interest rates, and technology valuations.  The selloff comes after a powerful AI-driven rally that pushed semiconductor stocks to…

Read more 12
SK Hynix Eyes U.S. Listing as Early as August Amid Strong AI Stock Demand 
📅 5 hours ago

SK Hynix Eyes U.S. Listing as Early as August Amid Strong AI Stock Demand 

SK Hynix is moving closer to a major milestone in its global growth strategy. Reports on June 10, 2026, revealed that the South Korean memory-chip giant is considering a U.S. stock market listing as early as August.  The timing comes as artificial intelligence continues to fuel strong demand for advanced semiconductor companies. With investors pouring…

Read more 12
Concord Biotech Shares Jump 5.9% After US FDA Approves Tofacitinib Arthritis Drug
📅 6 hours ago

Concord Biotech Shares Jump 5.9% After US FDA Approves Tofacitinib Arthritis Drug

Shares of Concord Biotech saw strong buying interest after a key global development. The stock rose around 5.9% in recent trading sessions after news of a US FDA approval related to its Tofacitinib-based arthritis drug. The trigger is important. The US Food and Drug Administration (FDA) approval opens doors to the world’s largest pharmaceutical market….

Read more 12
Top Indian Stocks: Ajanta Pharma, Bharti Airtel, IndiGo Lead Watchlist Amid Global Market Weakness
📅 8 hours ago

Top Indian Stocks: Ajanta Pharma, Bharti Airtel, IndiGo Lead Watchlist Amid Global Market Weakness

Indian equities entered the June 10 session with caution as global markets remained under pressure from rising crude oil prices and geopolitical concerns. Despite the weak backdrop, a few key stocks stood out due to major corporate developments, regulatory relief, and ownership changes. Market participants are closely tracking Ajanta Pharma, Bharti Airtel, and IndiGo as…

Read more 12
Swiss Hydrogen Stations Close as Agrola Exits Market, June 10
📅 11 hours ago

Swiss Hydrogen Stations Close as Agrola Exits Market, June 10

Agrola closes three hydrogen stations by end of 2026, signaling challenges for hydrogen vehicle adoption in Switzerland.

Read more 12
Trump Administration Strips Citizenship From 17 People, June 09
📅 16 hours ago

Trump Administration Strips Citizenship From 17 People, June 09

Justice Department files 17 denaturalization cases against individuals for fraud, sexual abuse, and serious offenses under Trump administration.

Read more 12
Crown Princess Victoria Tears Up Over Mother’s 50-Year Royal Duty, June 09
📅 1 day ago

Crown Princess Victoria Tears Up Over Mother’s 50-Year Royal Duty, June 09

Crown Princess Victoria honors Queen Silvia’s 50 years of royal service in emotional TV interview ahead of their golden anniversary.

Read more 12
Parabilis Medicines Targets Up to $2.3 Billion Valuation in Expanded U.S. IPO Amid Biotech Market Rally
📅 1 day ago

Parabilis Medicines Targets Up to $2.3 Billion Valuation in Expanded U.S. IPO Amid Biotech Market Rally

Parabilis Medicines is aiming for a valuation of nearly $2.3 billion through an expanded U.S. initial public offering, highlighting renewed investor confidence in the biotechnology sector. The Cambridge, Massachusetts-based company increased the size of its offering as demand for biotech IPOs continues to improve following a challenging period for the industry. The company now plans…

Read more 12
United Natural Foods Stock Plunges 11% After $7.72B Revenue Miss and Weak FY2026 Outlook
📅 1 day ago

United Natural Foods Stock Plunges 11% After $7.72B Revenue Miss and Weak FY2026 Outlook

Revenue came in. The stock came down. United Natural Foods (NYSE: UNFI) reported fiscal Q3 2026 results before the market open on June 9, 2026, covering the 13 weeks ended May 2, 2026. Wall Street had set the bar at $7.80 billion in revenue and $0.77 EPS, based on consensus estimates from 10 analysts. The…

Read more 12

RARE News FAQ